Selected article for: "acute kidney injury and lung kidney"
Author: Chen, Junzhe; Wang, Wenbiao; Tang, Ying; Huang, Xiao-ru; Yu, Xueqing; Lan, Hui-Yao
Title: Inflammatory stress in SARS-COV-2 associated Acute Kidney Injury
  • Cord-id: egjtko09
  • Document date: 2021_4_10
    • ID: egjtko09
    Snippet: Increasing clinical evidence shows that acute kidney injury (AKI) is a common and severe complication in critically ill COVID-19 patients. The older age, the severity of COVID-19 infection, the ethnicity, and the history of smoking, diabetes, hypertension, and cardiovascular disease are the risk factor for AKI in COVID-19 patients. Of them, inflammation may be a key player in the pathogenesis of AKI in patients with COVID-19. It is highly possible that SARS-COV-2 infection may trigger the activa
    Document: Increasing clinical evidence shows that acute kidney injury (AKI) is a common and severe complication in critically ill COVID-19 patients. The older age, the severity of COVID-19 infection, the ethnicity, and the history of smoking, diabetes, hypertension, and cardiovascular disease are the risk factor for AKI in COVID-19 patients. Of them, inflammation may be a key player in the pathogenesis of AKI in patients with COVID-19. It is highly possible that SARS-COV-2 infection may trigger the activation of multiple inflammatory pathways including angiotensin II, cytokine storm such as interleukin-6 (IL-6), C-reactive protein (CRP), TGF-β signaling, complement activation, and lung-kidney crosstalk to cause AKI. Thus, treatments by targeting these inflammatory molecules and pathways with a monoclonal antibody against IL-6 (Tocilizumab), C3 inhibitor AMY-101, anti-C5 antibody, anti-TGF-β OT-101, and the use of CRRT in critically ill patients may represent as novel and specific therapies for AKI in COVID-19 patients.

    Search related documents:
    Co phrase search for related documents
    • activation deposition and acute kidney injury: 1
    • activation deposition and acute kidney injury aki: 1
    • activation deposition and acute lung injury: 1, 2
    • activation deposition and acute respiratory distress syndrome: 1, 2, 3, 4
    • activation deposition and acute respiratory distress syndrome ards: 1, 2, 3, 4
    • activation deposition and acute respiratory syndrome: 1, 2, 3, 4, 5
    • acute ards respiratory distress syndrome and adaptive immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • acute ards respiratory distress syndrome and liver transplantation: 1, 2, 3
    • acute ards respiratory distress syndrome and locally systemically: 1
    • acute kidney injury aki and adaptive immune response: 1, 2
    • acute kidney injury aki and liver transplantation: 1, 2, 3
    • acute kidney injury and adaptive immune response: 1, 2
    • acute kidney injury and liver transplantation: 1, 2, 3, 4, 5
    • acute lung injury and adaptive immune response: 1, 2, 3, 4, 5
    • acute lung injury and liver transplantation: 1, 2
    • acute respiratory distress syndrome and adaptive immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
    • acute respiratory distress syndrome and liver transplantation: 1, 2, 3, 4, 5, 6, 7
    • acute respiratory distress syndrome and locally systemically: 1, 2, 3
    • acute respiratory distress syndrome ards and adaptive immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11